Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Revealed: secrets of ancient Chinese medicinal herb  Join our daily free Newsletter

MENAFN - AFP - 24/12/2012

No. of Ratings : 0
Digg This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story_s.aspx%3fstoryid%3d1093592873%26title%3dRevealed-secrets-of-ancient-Chinese-medicinal-herb Share This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story_s.aspx%3fstoryid%3d1093592873%26title%3dRevealed-secrets-of-ancient-Chinese-medicinal-herb Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!


 


(MENAFN - AFP) Scientists in the United States on Sunday offered a molecular-level explanation for how a Chinese herbal medicine used for more than 2,000 years tackles fever and eases malaria.

The herb is an extract of the root of a flowering plant called blue evergreen hydrangea, known in Chinese as chang shan and in Latin as Dichroa febrifuga Lour.

Chang shan's use dates back to the Han dynasty of 206 BC to 220 AD, according to ancient documents recording Chinese oral traditions.

In 2009, researchers made insights into its active ingredient, febrifuginone, which can be pharmaceutically made as a molecule called halofuginone.

They found that halofuginone prevented production of rogue Th17 immune cells which attack healthy cells, causing inflammation that leads to fever.

A study published in the journal Nature on Sunday found halofuginone works by hampering production of proteins for making "bad" Th17 cells, but not the "good" ones.

Specifically, it blocks molecules called transfer RNA (tRNA), whose job is to assemble a protein bit by bit, in line with the DNA code written in the gene.

As for malaria, halofuginone appears to interfere with the same protein-assembly process that enables malaria parasites to live in the blood, the study said.

"Our new results solved a mystery that has puzzled people about the mechanism that has been used to treat fever from a malaria infection going back probably 2,000 years or more," said Paul Schimmel, who headed the team at the Scripps Research Institute in California.

Halofuginone has been tested in small-scale human trials to treat cancer and muscular dystrophy. Drug engineers also eye it as a potential tool for combatting inflammatory bowel disease and rheumatoid arthritis, which are also autoimmune diseases.


 






  MENA News Headlines
May 24 2013Bankia sells City National Bank for 683m euros ,AFP
(MENAFN - AFP) Spain's bailed-out lender Bankia on Friday announced it would sell City National Bank of Florida to Chile's BCI for around 683 million euros ($883 million). The bank said in a ...

May 24 2013Bausch & Lomb near $9 bn sale to Valeant: source ,AFP
(MENAFN - AFP) Canadian pharmaceutical company Valeant is close to a deal to acquire US eye health company Bausch & Lomb for about $9 billion, a person familiar with the matter said Friday. A ...

May 24 2013Chile slaps $16 million fine on Canada mine company ,AFP
(MENAFN - AFP) Chile's environmental authorities slapped a $16.4 million fine Friday on Canadian mining company Barrick Gold for "serious" violations at its unfinished gold mine near the border ...

May 24 2013In Stockholm's suburbs, unemployment stokes unrest ,AFP
(MENAFN - AFP) Behind the well-kept lawns and flowerbeds of Husby, the immigrant-heavy Stockholm suburb where riots have raged for five straight nights, unemployment is fuelling despair among the ...

May 24 2013US stocks flat as bulls get cautious ,AFP
(MENAFN - AFP) US stocks closed flat Friday, reeling in early losses but showing caution following Japan's Thursday plunge and ahead of the three-day US Memorial Day holiday weekend. At the ...

May 24 2013IMF chief Lagarde avoids charges in French payout scandal ,AFP
(MENAFN - AFP) IMF chief Christine Lagarde avoided immediate charges Friday but was named an "assisted witness" after French prosecutors grilled her for two days over a state payout to a disgraced ...

May 24 2013Google eyes emerging markets networks: report ,AFP
(MENAFN - AFP) Google has become deeply involved in a series of projects to build and operate wireless networks in emerging markets including sub-Saharan Africa and Southeast Asia, a report said ...

May 24 2013Stalin police criticism sparks anti-Semitism row in Russia ,AFP
(MENAFN - AFP) An explosive comparison made by a liberal Russian politician between Stalin's agents and Hitler's secret police has provoked a storm of abusive criticism in Russia that has been ...

May 24 2013Hitler's shadow looms over anniversary of VW hometown ,AFP
(MENAFN - AFP) Europe's number one carmaker Volkswagen is not keen on celebrating the 75th birthday of its German hometown of Wolfsburg on Sunday because of the long shadow cast by Adolf Hitler ...

May 24 2013Fashion brands say street crime threatens Paris tourism ,AFP
(MENAFN - AFP) The streets of Paris are getting a reputation of being unsafe for tourists and this is a threat to business by the great brand names of French fashion, a top body representing the ...

more...


 
Click to Apply






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help